AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
(From Chemical Business NewsBase - Business Line)
Merck Sharp & Dohme India (Merck Sharp), a subsidiary of the US-based Merck & Co, plans to introduce its patented diabetes drug in India by late 2007 or 2008, besides initiating clinical studies for two drugs, as part of its research and development plans in India. The diabetes drug is undergoing Phase III trials and the company has obtained approval to commence clinical trials for …